These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 19286183)

  • 1. Assessing the global availability of misoprostol.
    Fernandez MM; Coeytaux F; de León RG; Harrison DL
    Int J Gynaecol Obstet; 2009 May; 105(2):180-6. PubMed ID: 19286183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stocking and over-the-counter sale of misoprostol for medical abortion in Ghana's community pharmacies: comparison of questionnaire and mystery client survey.
    Ganle JK; Busia NT; Baatiema L
    Int J Pharm Pract; 2020 Jun; 28(3):267-274. PubMed ID: 31746501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knowledge and provision of misoprostol among pharmacy workers in Senegal: a cross sectional study.
    Reiss K; Footman K; Burke E; Diop N; Ndao R; Mane B; van Min M; Ngo TD
    BMC Pregnancy Childbirth; 2017 Jul; 17(1):211. PubMed ID: 28673342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Availability and prescription of misoprostol for medical abortion in community pharmacies and associated factors in Accra, Ghana.
    Ganle JK; Busia NT; Maya E
    Int J Gynaecol Obstet; 2019 Feb; 144(2):167-173. PubMed ID: 30451283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Facilitating women's access to misoprostol through community-based advocacy in Kenya and Tanzania.
    Coeytaux F; Hessini L; Ejano N; Obbuyi A; Oguttu M; Osur J; Shuken K
    Int J Gynaecol Obstet; 2014 Apr; 125(1):53-5. PubMed ID: 24447412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Availability of medical abortion pills and the role of chemists: a study from Bihar and Jharkhand, India.
    Ganatra B; Manning V; Pallipamulla SP
    Reprod Health Matters; 2005 Nov; 13(26):65-74. PubMed ID: 16291487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Misoprostol in gynecology and obstetrics].
    Halmesmäki E; Nuutila M
    Duodecim; 1998; 114(14):1422-4. PubMed ID: 11552252
    [No Abstract]   [Full Text] [Related]  

  • 8. Misoprostol and declining abortion-related morbidity in Santo Domingo, Dominican Republic: a temporal association.
    Miller S; Lehman T; Campbell M; Hemmerling A; Anderson SB; Rodriguez H; Gonzalez WV; Cordero M; Calderon V
    BJOG; 2005 Sep; 112(9):1291-6. PubMed ID: 16101610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Availability and provision of misoprostol and other medicines for menstrual regulation among pharmacies in Bangladesh via mystery client survey.
    Huda FA; Ngo TD; Ahmed A; Alam A; Reichenbach L
    Int J Gynaecol Obstet; 2014 Feb; 124(2):164-8. PubMed ID: 24268354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case study of community-based distribution and use of Misoprostol and Chlorhexidine in Sokoto State, Nigeria.
    Cannon M; Charyeva Z; Oguntunde O; Sambisa W; Shoretire K; Orobaton N
    Glob Public Health; 2017 Dec; 12(12):1553-1567. PubMed ID: 27100376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of the Central American and Caribbean obstetrics and gynecology societies to the prevention of unsafe abortion in the region.
    de Gil MP
    Int J Gynaecol Obstet; 2014 Jul; 126 Suppl 1():S10-2. PubMed ID: 24745695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reducing maternal mortality due to elective abortion: Potential impact of misoprostol in low-resource settings.
    Harper CC; Blanchard K; Grossman D; Henderson JT; Darney PD
    Int J Gynaecol Obstet; 2007 Jul; 98(1):66-9. PubMed ID: 17466303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The true cost differential between mifepristone and misoprostol and misoprostol-alone regimens for medical abortion.
    Creinin MD; Shore E; Balasubramanian S; Harwood B
    Contraception; 2005 Jan; 71(1):26-30. PubMed ID: 15639068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. WHO recommendations for misoprostol use for obstetric and gynecologic indications.
    Tang J; Kapp N; Dragoman M; de Souza JP
    Int J Gynaecol Obstet; 2013 May; 121(2):186-9. PubMed ID: 23433680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Availability and acceptability of medical abortion in Nepal: health care providers' perspectives.
    Tamang A; Tamang J
    Reprod Health Matters; 2005 Nov; 13(26):110-9. PubMed ID: 16291492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Misoprostol in obstetrics and gynaecology--unregistered, dangerous and essential.
    Hofmeyr GJ
    S Afr Med J; 1998 May; 88(5):535-6. PubMed ID: 9638117
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacy provision of medical abortifacients in a Latin American city.
    Lara D; Abuabara K; Grossman D; Díaz-Olavarrieta C
    Contraception; 2006 Nov; 74(5):394-9. PubMed ID: 17046381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Stalled Revolution? Misoprostol and the Pharmaceuticalization of Reproductive Health in Francophone Africa.
    Suh S
    Front Sociol; 2021; 6():590556. PubMed ID: 33954164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Legalized abortions reduced maternal mortality in South Africa. Morbidity and mortality before and after the change of legislation].
    Bendz E; Liljequist VA; Bergström S
    Lakartidningen; 2008 Oct 8-14; 105(41):2855-7. PubMed ID: 19009900
    [No Abstract]   [Full Text] [Related]  

  • 20. Contribution of obstetrics and gynecology societies in West and Central African countries to the prevention of unsafe abortion.
    Leke RJ
    Int J Gynaecol Obstet; 2014 Jul; 126 Suppl 1():S17-9. PubMed ID: 24731440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.